CDSCO Painkiller and Antibiotic Advisory: Why Overuse Raises Chronic Kidney Disease Risks
CDSCO warned against indiscriminate painkiller and antibiotic use, citing chronic kidney disease and antimicrobial resistance. Emphasizing Schedule H/H1 prescription mandates, the advisory directs clinicians to practice stewardship, pharmacists to enforce retail compliance, and patients to avoid self-medication.
The Central Drugs Standard Control Organisation (CDSCO) has issued a safety advisory cautioning clinicians, pharmacists, and the public against the overuse of painkillers and antibiotics, highlighting elevated risks of chronic kidney disease (CKD) and antimicrobial resistance.
Regulatory Mandates and Schedules
- The Advisory: Issued via the Directorate General of Health Services (DGHS) on September 21, the directive stresses that non-steroidal anti-inflammatory drugs (NSAIDs) and antibiotics require clinical indication and medical supervision. CDSCO Warns Against 'Made in Pakistan' Goree and Chandni Whitening Creams; Here's Why.
- Statutory Classification: Governance falls under the Drugs and Cosmetics Act, 1940. Under the Drugs Rules, 1945, most NSAIDs fall under Schedule H, while most antibiotics fall under Schedule H1, legally prohibiting retail sale without a registered medical practitioner's prescription.
- Mandatory Warning Text: Schedule H1 formulations carry mandatory statutory labelling: “It is dangerous to take this preparation except in accordance with the medical advice. Not to be sold by retail without the prescription of a Registered Medical Practitioner", reports CDCSO.
CDSCO Warns Against Indiscriminate Painkiller, Antibiotic Use
The Central Drugs Standard Control Organisation (CDSCO) has issued an advisory circular addressed to healthcare professionals, pharmacies, retailers, distributors, and hospitals regarding the indiscriminate use of painkillers, specifically Non-Steroidal Anti-Inflammatory Drugs… pic.twitter.com/aXQIO1NTbW
— ANI (@ANI) September 22, 2026
Public Health Advisory Guidelines
- Self-Medication Warnings: The DGHS cautioned against self-treatment for uncomplicated viral infections or persistent symptoms (pain, fever) using leftover or shared antibiotics.
- Renal Risk Factors: Patients with pre-existing kidney disease, dehydration, or cardiovascular comorbidity are advised to consult physicians before initiating NSAIDs.
- Compliance: Leftover antibiotics must not be repurposed or shared.
Directives for Clinicians and Pharmacists
- Prescribing Standards: Healthcare providers are instructed to prescribe NSAIDs at the lowest effective dose for the shortest duration, particularly in renal-compromised cohorts. Antimicrobial stewardship governs antibiotic selection, avoiding unnecessary combination therapies and prolonged courses.
- Retailer Accountability: Pharmacists and distributors are directed to enforce Schedule H/H1 retail dispensing rules strictly and refrain from facilitating over-the-counter access.
- Institutional Role: Hospitals must bolster prescription review systems, while state and union territory drug controllers are tasked with public awareness outreach.
Broader Clinical Context
Indiscriminate NSAID usage reduces renal prostaglandin synthesis, leading to acute kidney injury or cumulative interstitial nephritis progressing to CKD. Concurrently, unindicated antibiotic consumption accelerates global antimicrobial resistance, prompting apex regulators worldwide to enforce tighter prescription audits at the retail interface.
(The above story first appeared on LatestLY on Sep 23, 2026 07:45 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
